General Electric Co. (GE) - Get Report shares were flat in late morning trading Thursday following a note from Standpoint Research saying that the recent sell off the stock has endured has been overdone. The firm raised its rating to "hold" from "buy" on valuation.
The firm set a price target of $24 on the shares which Standpoint said would be reached through a market correction. GE closed the previous day's trading just above $27 per share.
Over the past 12 months, GE shares have fallen 11.4% and are down 13% year to date.
GE stock was down 0.3% to $26.99 early Thursday afternoon.
What's Hot On TheStreet
Happy birthday iPhone: Apple's (AAPL) - Get Report iPhone turns 10 years old today! What an amazing product Steve Jobs and his team created. But, as TheStreet's Natalie Walters points out, the next five years for Apple could be radically different. Sales could well be boosted by new, non-iPhone products such as smart glasses and autonomous car technologies. Walters also mentions that iPhone demand may peak in 2019.
Blue Apron falters: Blue Apron (APRN) - Get Report plans an initial public offering on Thursday seeking a valuation of about $2 billion. That's down significantly from a $3.2 billion valuation it had previously hoped to achieve. In the public sphere, the New York-based meal kit delivery service's IPO comes at an unsettling time, points out TheStreet's Ron Orol, as the markets begin to digest Amazon Inc.'s (AMZN) - Get Report mega $13.4 billion acquisition of Whole Foods Market Inc. (WFM) . Moreover, investors have questioned Blue Apron's business model -- it hasn't turned a profit since 2012 due to rising marketing and distribution costs.
Regulators outsmarted: With questions swirling whether its combination would get approved by regulators, Walgreens Boots Alliance (WBA) - Get Report and Rite-Aid (RAD) - Get Reportstruck a clever deal on Thursday. Walgreens will pay $5.175 billion to Rite-Aid in cash and receive 2,186 stores in return. Walgreens will also pay Rite-Aid a $325 million termination fee for its planned buyout of the company.
Walgreens will be an even bigger drug-selling beast, with more than 15,000 stores spanning 11 countries. As for Rite-Aid, it will be left with about 2,300 stores once the deal closes in six months.
Visit here for the latest business headlines.
Read More Trending Articles:
- Painful Day for Nasdaq as Tech Torpedoes Wall Street Deep Into the Red
- 5 of the Worst Cruise Ships According to the CDC's Sanitary Inspection List
- Walgreens and Rite-Aid Just Laughed in the Face of Regulators, Strike One Clever New Deal
- Here's Why Amazon Could Feast on the Remaining Carcass of Rite Aid After Failed Walgreens Merger
- Walgreens Punches One of Its Biggest Rivals in the Face With This Surprising New Deal